Alix Ventures

Alix Ventures is a venture capital firm dedicated to supporting early-stage life science startups that are engineering biology to drive radical advances in human health. The firm focuses on the rapidly evolving TechBio sector, which merges technology and biology, aiming to build transformative companies that significantly impact the quality and effectiveness of patient care. Alix Ventures partners with passionate and accomplished founders to solve some of the world's most pressing problems in life sciences.

The firm's investment strategy emphasizes sectors such as life sciences, healthcare, biotechnology, and TechBio, targeting companies at various stages including seed, early stage, Series A, Series B, and growth. Alix Ventures is particularly interested in startups that are engineering biology to drive radical advances in human health. The firm operates primarily in the United States, with a strong presence in San Francisco, California.

Alix Ventures has a track record of supporting innovative companies in the life sciences sector. For instance, the firm has invested in Elegen, a company developing groundbreaking technologies for rapid, scalable DNA synthesis. Elegen aims to synthesize thousands of custom DNA sequences inexpensively and on demand, ushering in a new era in the life and biomedical sciences. This investment reflects Alix Ventures' commitment to advancing patient care through technological innovation in the life sciences sector.